Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardio Diagnostics Holdings Inc. - Common stock (NQ: CDIO )

0.2108 +0.0008 (+0.38%)
Streaming Delayed Price Updated: 3:57 PM EDT, Oct 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cardio Diagnostics Holdings Inc. - Common stock

< Previous 1 2 3 Next >
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
With New Lab/Operations Hub, Cardio Diagnostics Says it’s Prepared To Meet Uptake In Demand, Announces New Partner Initiative
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital’s Heart Attack Prevention Clinic on Coronary Artery Disease Study
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics Solution
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and Education
From Cardio Diagnostics
Via Business Wire
Cardio Diagnostics Holdings, Inc Sponsors Becker’s Hospital Review 13th Annual Meeting
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million
From Cardio Diagnostics
Via Business Wire
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application
From Cardio Diagnostics Holdings Inc
Via Business Wire
Cardio Diagnostics (NASDAQ: CDIO) Unveils Innovative Blood Test to Detect Early Stages of Coronary Heart Disease
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) is engaged as an artificial intelligence-driven precision cardiovascular medicine company, which is focused on 
Via Spotlight Growth
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease
From Cardio Diagnostics Holdings Inc
Via Business Wire
Cardio Diagnostics Holdings Inc to Debut PrecisionCHD™ at the American College of Cardiology’s 72nd Annual Scientific Session
From Cardio Diagnostics Holdings Inc
Via Business Wire
Healing Sanctuary Clinic Partners With Cardio Diagnostics Holdings Inc to Offer the Epi+Gen CHD Test in their Medical Practice in Idaho
From Cardio Diagnostics Holdings Inc
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.